Cargando…

Utility of short-term telemetry heart rhythm monitoring and CHA(2)DS(2)-VASc stratification in patients presenting with suspected cerebrovascular accident

BACKGROUND: Inpatient telemetry heart rhythm monitoring overuse has been linked to higher healthcare costs. AIM: To evaluate if CHA(2)DS(2)-VASc score could be used to indicate if a patient admitted with possible cerebrovascular accident (CVA) or transient ischemic attack (TIA) requires inpatient te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhuiya, Tanzim, Roman, Sherif, Aydin, Taner, Patel, Bhakti, Zeltser, Roman, Makaryus, Amgad N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993929/ https://www.ncbi.nlm.nih.gov/pubmed/36911749 http://dx.doi.org/10.4330/wjc.v15.i2.56

Ejemplares similares

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

The Clinical Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Cardiac Diastolic Dysfunction
por: Bhuiya, Sabreen, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Assessment of CHA(2)DS(2)-VASc score for predicting cardiovascular and cerebrovascular outcomes in acute myocardial infarction patients
por: Li, Chen-Yu, et al.
Publicado: (2018)

Impact of cardiologist intervention on guideline-directed use of statin therapy
por: Cassagnol, Manouchkathe, et al.
Publicado: (2020)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Risk Stratification Using the CHA(2)DS(2)‐VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network
por: Parodi, Guido, et al.
Publicado: (2017)

CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
por: Wang, Bo-Yuan, et al.
Publicado: (2021)

Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score
por: Chen, Po-Han, et al.
Publicado: (2023)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions
por: Farshadmand, Jonathan, et al.
Publicado: (2022)

Predictive value of CHA2DS2-VASc score in radial artery occlusion after transradial coronary angiography
por: Nadir, Aydın, et al.
Publicado: (2023)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Atrial high-rate episodes intensify R(2)CHA(2)DS(2)-VASc score for prognostic stratification in pacemaker patients
por: Li, Yi-Pan, et al.
Publicado: (2023)

Presence of Permanent Pacemakers: Implications for Elderly Patients Presenting with Traumatic Injuries
por: Bhuiya, Tanzim, et al.
Publicado: (2023)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?
por: Ahmed, Ammar, et al.
Publicado: (2021)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Correction: Farshadmand et al. Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions. Healthcare 2022, 10, 2417
por: Farshadmand, Jonathan, et al.
Publicado: (2023)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Association of CHA2DS2-VASc score with successful recanalization in acute ischemic stroke patients undergoing endovascular thrombectomy
por: Nasifov, Muharrem, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA (2)DS (2)-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study
por: Lee, Yi, et al.
Publicado: (2021)

The CHA(2)DS(2)-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study
por: Aksoy, Fatih, et al.
Publicado: (2019)

The CHA(2)DS(2)‐VASc score as a predictor of high mortality in hospitalized heart failure patients
por: Yoshihisa, Akiomi, et al.
Publicado: (2016)

Association between modified CHA(2)DS(2)-VASc Score with Ankle-Brachial index < 0.9
por: Hsu, Po-Chao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eosdgv3ba1u6baq6hsrdg3cdv4